Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | ADORA2A | P29274 | 7/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 5/20 | 0.40 |
| ▸ | HPGD | P15428 | 5/20 | 0.38 |
| ▸ | WHR1 | P49842 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.34 |
| ▸ | PI4KA | P42356 | 1/20 | 0.34 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.34 |
| ▸ | CASP3 | P42574 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.34 |
| ▸ | RELA | Q04206 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18158658 | 1.00 | MEN1 (0.42) | MEN1KMT2AATMADORA2AADORA1 | |
| SCHEMBL19106397 | 1.00 | MEN1 (0.42) | MEN1KMT2AATMADORA2AADORA1 | |
| SCHEMBL19497513 | 1.00 | MEN1 (0.42) | MEN1KMT2AATMADORA2AADORA1 | |
| SCHEMBL18158696 | 1.00 | MEN1 (0.42) | MEN1KMT2AATMADORA2AADORA1 | |
| SCHEMBL18017913 | 0.99 | ADORA2A (0.41) | MEN1KMT2AATMADORA2AADORA1 | |
| SCHEMBL18017891 | 0.99 | ADORA2A (0.41) | MEN1KMT2AATMADORA2AADORA1 | |
| SCHEMBL18017819 | 0.99 | ADORA2A (0.41) | MEN1KMT2AATMADORA2AADORA1 | |
| SCHEMBL18017845 | 0.99 | ADORA2A (0.41) | MEN1KMT2AATMADORA2AADORA1 | |
| SCHEMBL18017927 | 0.97 | ADORA2A (0.40) | MEN1KMT2AATMADORA2AADORA1 | |
| SCHEMBL18018405 | 0.97 | ADORA2A (0.40) | MEN1KMT2AATMADORA2AADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170309829-A1 | COMPOSITION FOR ORGANIC OPTOELECTRONIC ELEMENT, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2017-10-26 | — | — | US | disclosed |
| US-20170309829-A1 | COMPOSITION FOR ORGANIC OPTOELECTRONIC ELEMENT, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2017-10-26 | — | — | US | disclosed |
| US-20160308142-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-10-20 | — | — | US | disclosed |
| US-20160308142-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160308142-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNE2 | MEN1 838/4885KMT2A 2013/4885ATM 1355/4885 |
| US-20170309829-A1 | COMPOSITION FOR ORGANIC OPTOELECTRONIC ELEMENT, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE | OCIAD2, OCIAD1, OR10J3 | MEN1 2593/4885KMT2A 3837/4885ATM 4302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.